Prudential Financial Inc Biotechnology

Prudential Financial Inc

$74.4 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IBRX Immunity Bio, Inc.	$965M	$65,000 0.0% of portfolio	24,740	Q2 2025 New
GOSS Gossamer Bio, Inc.	$250M	$62,000 0.0% of portfolio	50,415	Q2 2025 Added 7.15%
IOVA Iovance Biotherapeutics, Inc.	$376M	$59,000 0.0% of portfolio	34,830	Q2 2025 Added 70.82%
CTMX Cytom X Therapeutics, Inc.	$138M	$58,000 0.0% of portfolio	25,700	Q2 2025 Reduced 68.47%
ABUS Arbutus Biopharma Corp	$613M	$56,000 0.0% of portfolio	18,255	Q2 2025 Added 71.49%
NUVB Nuvation Bio Inc.	$758M	$56,000 0.0% of portfolio	28,905	Q2 2025 Added 112.3%
GLUE Monte Rosa Therapeutics, Inc.	$224M	$54,000 0.0% of portfolio	12,054	Q2 2025 New
TSHA Taysha Gene Therapies, Inc.	$157M	$52,000 0.0% of portfolio	22,790	Q2 2025 Added 50.53%
SANA Sana Biotechnology, Inc.	$571M	$49,000 0.0% of portfolio	18,260	Q2 2025 New
ALT Altimmune, Inc.	$182M	$43,000 0.0% of portfolio	11,195	Q2 2025 New
AVIR Atea Pharmaceuticals, Inc.	$271M	$36,000 0.0% of portfolio	10,135	Q2 2025 New
MRVI Maravai Lifesciences Holdings, Inc.	$350M	$35,000 0.0% of portfolio	14,865	Q2 2025 New
BDTX Black Diamond Therapeutics, Inc.	$109M	$32,000 0.0% of portfolio	13,100	Q2 2025 New
ALEC Alector, Inc.	$228M	$29,000 0.0% of portfolio	21,322	Q2 2025 New
SVRA Savara Inc	$435M	$29,000 0.0% of portfolio	12,995	Q2 2025 New
ANNX Annexon, Inc.	$101M	$28,000 0.0% of portfolio	11,670	Q2 2025 Reduced 79.57%
EDIT Editas Medicine, Inc.	$192M	$28,000 0.0% of portfolio	12,937	Q2 2025 Reduced 83.82%
HUMA Humacyte, Inc.	$145M	$27,000 0.0% of portfolio	13,165	Q2 2025 New
STRO Sutro Biopharma, Inc.	$51.1M	$25,000 0.0% of portfolio	35,500	Q2 2025 Reduced 94.13%
IPSC Century Therapeutics, Inc.	$30M	$25,000 0.0% of portfolio	45,400	Q2 2025 New
QSI Quantum Si Inc	$127M	$25,000 0.0% of portfolio	12,850	Q2 2025 New
MGNX Macrogenics Inc	$108M	$24,000 0.0% of portfolio	20,000	Q2 2025 Reduced 76.95%
FATE Fate Therapeutics Inc	$95.1M	$24,000 0.0% of portfolio	21,791	Q2 2025 Reduced 70.27%
RCKT Rocket Pharmaceuticals, Inc.	$247M	$24,000 0.0% of portfolio	10,165	Q2 2025 New
LIFE A Tyr Pharma Inc	$53.2M	$23,000 0.0% of portfolio	12,390	Q2 2025 New
ERAS Erasca, Inc.	$189M	$23,000 0.0% of portfolio	18,161	Q2 2025 Added 65.84%
ZNTL Zentalis Pharmaceuticals, Inc.	$92.9M	$21,000 0.0% of portfolio	18,900	Q2 2025 Reduced 40.88%
RPTX Repare Therapeutics Inc.	$71.7M	$20,000 0.0% of portfolio	14,900	Q2 2025 Reduced 68.43%
ALLO Allogene Therapeutics, Inc.	$164M	$18,000 0.0% of portfolio	15,930	Q2 2025 Added 34.03%
LCTX Lineage Cell Therapeutics, Inc.	$210M	$14,000 0.0% of portfolio	15,700	Q2 2025 Reduced 51.23%
CRBU Caribou Biosciences, Inc.	$110M	$13,000 0.0% of portfolio	10,600	Q2 2025 New
VXRT Vaxart, Inc.	$49.3M	$13,000 0.0% of portfolio	31,100	Q2 2025 Added 20.08%
EQ Equillium, Inc.	$67M	$12,000 0.0% of portfolio	39,200	Q2 2025 New
CHRS Coherus Bio Sciences, Inc.	$106M	$10,000 0.0% of portfolio	14,980	Q2 2025 New
GBIO Generation Bio Co.	$344M	$7,000 0.0% of portfolio	22,100	Q2 2025 Reduced 37.88%
MRSN Mersana Therapeutics, Inc.	$684M	$4,000 0.0% of portfolio	14,900	Q2 2025 Reduced 75.79%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.